CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia

The potential of CD123-targeted therapies in acute lymphoblastic leukemia/lymphoma remains largely unexplored. We examined CD123 expression levels in a large cohort of patients with acute lymphoblastic leukemia/lymphoma and assessed the in vitro impact of IMGN632, a conjugate of CD123-binding antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelova, Evgeniya, Audette, Charlene, Kovtun, Yelena, Daver, Naval, Wang, Sa A., Pierce, Sherry, Konoplev, Sergej N., Khogeer, Haitham, Jorgensen, Jeffrey L., Konopleva, Marina, Zweidler-McKay, Patrick A., Medeiros, L. Jeffrey, Kantarjian, Hagop M., Jabbour, Elias J., Khoury, Joseph D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442980/
https://www.ncbi.nlm.nih.gov/pubmed/30361418
http://dx.doi.org/10.3324/haematol.2018.205252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442980/
https://www.ncbi.nlm.nih.gov/pubmed/30361418
http://dx.doi.org/10.3324/haematol.2018.205252

Ejemplares similares